IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sands Capital Alternatives, LLC

Q3 2021 Holdings

Filed 2021-11-04 | 13 holdings | $60.9M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2021-11-12) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Acumen Pharmaceuticals, Inc(ABOS)COM00509G209$50.8M3,417,07583.4%
Candel Therapeutics, Inc(CADL)ACOM137404109$8.8M811,73714.5%
Absci Corp.(ABSI)COM00091E109$672.0K57,8041.1%
Uipath Inc(PATH)COM CL A90364P105$200.5K3,811,7790.3%
Doordash Inc(DASH)COM CL A25809K105$129.8K630,2170.2%
Dice Therapeutics, Inc.COM23345J104$103.1K3,148,9700.2%
Snowflake Inc(SNOW)COM CL A833445109$95.7K316,5760.2%
Karuna Therapeutics, Inc.COM48576A100$32.8K267,8950.1%
Taysha Gene Therapies Inc(TSHA)COM877619106$13.5K724,8730.0%
908 Devices Inc(MASS)COM65443P102$10.6K326,4270.0%
Repligen Corp.(RGEN)COM759916109$6.5K22,5440.0%
Tarsus Pharmaceuticals Inc(TARS)COM87650L103$5.6K260,0000.0%
Spruce Biosciences IncCOM85209E109$4.7K787,0070.0%